Compositions and methods for FeLV vaccination
US5152982A · kind A · utility
2Cited by
12References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1991 |
| Grant date | Oct 6, 1992 |
| Priority date | — |
| Expiry date | Dec 10, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/819
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel methods and compositions are provided for vaccinating a host susceptible to viral infection. Particularly, an initial injection is employed of one or more polypeptides associated with the host immune response to the pathogen followed by administration of the pathogen in attenuated form, particularly having a deletion associated with the gene expressing at least one of said polypeptides. In this manner, hosts may be vaccinated so as to maintain a strong defensive posture against infection from the pathogen. The method is specifically illustrated with feline leukemia virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.